Influence
March 31, 2022

Regenstrief researcher will be part of life sciences expert panel

Regenstrief Research Scientist NiCole Keith, PhD, will join other Central Indiana life sciences leaders to discuss Indiana’s life-sciences industry.

The panel will elaborate on the pandemic’s effect on research and product development, federal policies and industry trends, and venture capital investments in Indiana companies, among other subjects. In addition to Dr. Keith, featured panelists are Kent Hawryluk, MBX Biosciences, Inc.; Marcela A. Kirberger, Elanco Animal Health, Inc.; Theresa S. Mayer, Purdue University; and Brandy Matthews, Eli Lilly and Company. The discussion will be moderated by Indianapolis Business Journal reporter John Russell.

Dr. Keith is a physical activity researcher specializing in community-based participatory research with a focus on health equity. She co-created the Physically Active Residential Communities and Schools (PARCS) program — a partnership among Indianapolis Public Schools, Eskenazi Health Federally Qualified Health Centers and IUPUI. This award-winning program provides exercise opportunities for more than 3,000 adults and children living in Indianapolis inner-city communities. She also helped to write the State of Aging in Indiana report.

In addition to her role as a research scientist at Regenstrief, Dr. Keith is the associate dean of faculty affairs and a professor at Indiana University School of Health & Human Sciences. Dr. Keith was the 2020-2021 president of the American College of Sports Medicine, an Indianapolis-based organization of more than 55,000 members.

The expert panel will be featured as part of the IBJ Power Breakfast Series.

register here

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher